GlycoMimetics Inc (NAS:GLYC)
$ 0.3131 -0.0079 (-2.46%) Market Cap: 20.19 Mil Enterprise Value: 6.06 Mil PE Ratio: 0 PB Ratio: 1.78 GF Score: 30/100

Q3 2020 GlycoMimetics Inc Earnings Call Transcript

Nov 06, 2020 / 01:30PM GMT
Release Date Price: $2.98 (-2.30%)
Operator

Good morning, and thank you all for joining GlycoMimetics Corporate Update Conference Call. (Operator Instructions) I would now like to turn the call over to Ms. Shari Annes of the Investor Relations Group at GlycoMimetics. Please go ahead.

Shari Annes;Investor Relations

Good morning. Today, we will review our accomplishments and financial results for the third quarter of 2020. We'll also be updating you on several more recent achievements primarily related to emerging data from the Phase III RESET trial evaluating rivipansel in vaso-occlusive crisis in sickle cell disease.

The press release we issued this morning is available on the company's website at www.glycomimetics.com under the Investors tab. This call is being recorded. A dial-in phone replay will be available 24 hours after the close of the call. The webcast replay will also be available in the Investor Relations section of the company's website for 30 days.

Joining me on the call from GlycoMimetics are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot